A step towards global harmonisation of GMP inspection protocols
Linking purchase of electoral bonds to inaction on questionable quality standards is yet another warning to all pharma companies…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
UK-MHRA
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Venus Remedies gets marketing authorisation from UK MHRA for Cisplatin
The company intends to increase sales in the UK to approximately two million euros by focusing on seven molecules which are…
Marksans Pharma gets UK MHRA nod for diarrhoea medication
The capsules will be manufactured at the company's Goa-based oral dosage facility
The Brexit effect
Brexit is finally a reality and though India Pharma Inc expects some glitches in the short-term, it is optimistic about its impact…
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March
UK MHRA commences accelerated review for AstraZeneca’s COVID-19 vaccine candidate
In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing…
UK MHRA inspection of Strides facility at Puducherry concludes successfully
The company receives renewed GMP status for the facility from UK MHRA
Lupin’s Pithampur facilities complete successful UK MHRA inspection
The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020 Lupin has…
Lupin’s Inhalation Research Center, Florida receives EIR from US FDA
Lupin’s Inhalation Research Center at Coral Springs, Florida focuses on research and development of respiratory products for the…